These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1707996)

  • 1. [Immunological abnormalities in diabetes mellitus].
    Sugita M; Kumagai S; Imura H
    Nihon Rinsho; 1990 Dec; 48 Suppl():761-6. PubMed ID: 1707996
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmunity. A diversity of diabetes.
    Parham P
    Nature; 1990 Jun; 345(6277):662-4. PubMed ID: 1972776
    [No Abstract]   [Full Text] [Related]  

  • 3. [Role of autoimmune processes in the pathogenesis of diabetes mellitus].
    Sil'nitskiĭ PA; Shabanova LF
    Klin Med (Mosk); 1980 Oct; 58(10):22-6. PubMed ID: 7003240
    [No Abstract]   [Full Text] [Related]  

  • 4. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune endocrine diseases.
    De Baets MH
    Year Immunol; 1989; 4():264-75. PubMed ID: 2564710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cross-reactivity between major histocompatibility complex class II antigens in mice NOD and an islet antigen with 58 kDA molecular weight].
    Boitard C; Pham-Gia H; Becourt C; Bach JF
    C R Acad Sci III; 1989; 309(7):229-34. PubMed ID: 2505891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
    Reich EP; Sherwin RS; Kanagawa O; Janeway CA
    Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
    Slattery RM; Kjer-Nielsen L; Allison J; Charlton B; Mandel TE; Miller JF
    Nature; 1990 Jun; 345(6277):724-6. PubMed ID: 1972779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of autoimmune type I diabetes in biobreeding (BB) rats by a newly established, autoreactive T cell line from acutely diabetic BB rats.
    Nagata M; Yoon JW
    J Immunol; 1994 Oct; 153(8):3775-83. PubMed ID: 7930594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes.
    Guerder S; Eynon EE; Flavell RA
    J Immunol; 1998 Sep; 161(5):2128-40. PubMed ID: 9725204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant.
    Böhme J; Haskins K; Stecha P; van Ewijk W; LeMeur M; Gerlinger P; Benoist C; Mathis D
    Science; 1989 Jun; 244(4909):1179-83. PubMed ID: 2499048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of rat islet allografts with the use of ultraviolet irradiation, without immunosuppression.
    Hardy MA; Lau H; Reemtsma K
    Transplant Proc; 1984 Jun; 16(3):865-9. PubMed ID: 6233774
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
    Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
    Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.
    Miyazaki T; Uno M; Uehira M; Kikutani H; Kishimoto T; Kimoto M; Nishimoto H; Miyazaki J; Yamamura K
    Nature; 1990 Jun; 345(6277):722-4. PubMed ID: 2113614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet transplantation in experimental diabetes of the rat. IX. In vitro culture reduces Ia-bearing cells in rat islets.
    Forsen JW; Blum BE; Bretzel RG; Federlin K
    Horm Metab Res; 1984 Dec; 16(12):671-2. PubMed ID: 6441764
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible role of isoantibodies to pancreatic antigens in diabetes.
    Tripathi KK; Tiwari R; Vadehra DV; Gupta KG
    Indian J Exp Biol; 1982 Feb; 20(2):112-6. PubMed ID: 7049908
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-CD4 antibodies in diabetes.
    Shizuru JA; Fathman CG
    Immunol Ser; 1993; 59():237-52. PubMed ID: 8096401
    [No Abstract]   [Full Text] [Related]  

  • 20. New insights into insulin dependent diabetes mellitus from studies with transgenic mouse models.
    Grewal IS; Flavell RA
    Lab Invest; 1997 Jan; 76(1):3-10. PubMed ID: 9010445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.